Skip to Main

News

Research could lead to treatments for obesity, extreme weight loss

 

Mysterious cells that secrete hormones in the large intestine play a key role in regulating body weight through their relationship with intestinal bacteria, a study led by UT Southwestern Medical Center researchers suggests. Their findings, published in Nature Metabolism, could lead to new treatments for obesity and extreme weight loss.

UT System initiative funds trauma research to improve care

 

A new initiative funded by The University of Texas System and the state of Texas seeks to improve care for trauma patients.

Tumor mutations may not predict response to immunotherapy

 

The number of mutations in the DNA of cancerous tumors may not be an indicator of how well patients will respond to immune checkpoint inhibitors (ICIs), a commonly prescribed type of immunotherapy, a team led by UT Southwestern Medical Center reported in a retrospective study.

Fibromyalgia, IBS patients linked to multiple-drug intolerance

 

Patients with fibromyalgia and irritable bowel syndrome (IBS) who take multiple medications are more likely to develop severe drug intolerance than healthy patients, UT Southwestern Medical Center researchers reported.

Children’s Health and UT Southwestern receive $100 million donation from the Pogue family for new $5 billion Dallas pediatric campus

 

Children's HealthSM and UT Southwestern Medical Center on Wednesday announced a historic gift of $100 million from the Jean and Mack Pogue family in support of the $5 billion transformative new Dallas pediatric campus, unveiled earlier this year. The gift from the Pogue Foundation is one of only four $100 million philanthropic gifts ever publicly announced in North Texas, and it is the largest donation yet to the new pediatric campus project, which will replace the existing Children’s Medical Center Dallas.

Mutations protected mice from B-cell cancers

 

By completely or even partially depleting a protein called midnolin in B cells, UT Southwestern Medical Center researchers suppressed leukemia and lymphoma in a mouse model genetically prone to these cancers.

ChatGPT can extract data from clinical notes

 

ChatGPT, the artificial intelligence (AI) chatbot designed to assist with language-based tasks, can effectively extract data for research purposes from physicians’ clinical notes, UT Southwestern Medical Center researchers report in a new study.

Combined therapy makes headway for liver cancer

 

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two clinical trial conducted by UT Southwestern Medical Center.

Cancer cell–immune cell interactions predict immunotherapy response

 

By examining which genes were turned on and off in a mix of cell types from breast cancer biopsies, a team led by UT Southwestern Medical Center researchers developed a tool that can accurately predict which patients with breast cancer will respond to immunotherapies.

Blocking gene may halt growth of breast cancer cells

 

Shutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to a standard therapy known as CDK4/6 inhibitors, UT Southwestern Medical Center researchers showed in a new study.